| Pharmaceutical Information |
| Drug Name |
Methsuximide |
| Drug ID |
BADD_D01422 |
| Description |
Mesuximide (or methsuximide) is an anticonvulsant medication. It is sold by Pfizer under the name Petinutin. |
| Indications and Usage |
For the control of absence (petit mal) seizures that are refractory to other drugs. |
| Marketing Status |
Prescription |
| ATC Code |
N03AD03 |
| DrugBank ID |
DB05246
|
| KEGG ID |
D00404
|
| MeSH ID |
C100286
|
| PubChem ID |
6476
|
| TTD Drug ID |
D08EOD
|
| NDC Product Code |
0071-0525; 58159-063 |
| Synonyms |
methsuximide | mesuximide | N,2-dimethyl-2-phenylsuccinimide | mesuximid | methsuximide, (+-)-isomer | Celontin | Petinutin | methsuximide, (+)-isomer | methsuximide, (-)-isomer |
|
| Chemical Information |
| Molecular Formula |
C12H13NO2 |
| CAS Registry Number |
77-41-8 |
| SMILES |
CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
